Research Summaries

Barak Gaster: Hi, my name is Barak Gaster. I'm a professor of medicine at the University of Washington in Seattle, and I'm a primary care doctor.

Barak Gaster: Hi, my name is Barak Gaster. I'm a professor of medicine at the University of Washington in Seattle, and I'm a primary care doctor.

W.

W.

Symptoms of irritable bowel system occur with some frequency in patients already diagnosed with inflammatory bowel disease. Kerri Glassner, DO, explained the best way to approach diagnosing and treating...

TKTKTKTKTKTKT

Researchers set out to determine whether inhibiting interleukin-13 could alleviate the most serious complication of eosinophilic esophagitis. A 16-week study yielded promising results on 4 key measures. ...

Researchers set out to determine whether inhibiting interleukin-13 could alleviate the most serious complication of eosinophilic esophagitis. A 16-week study yielded promising results on 4 key measures. ...

Researchers set out to determine whether inhibiting interleukin-13 could alleviate the most serious complication of eosinophilic esophagitis. A 16-week study yielded promising results on 4 key measures. ...

Researchers set out to determine whether inhibiting interleukin-13 could alleviate the most serious complication of eosinophilic esophagitis. A 16-week study yielded promising results on 4 key measures. ...